 |
 |
|||||
  |
 |
 |
 |
 |
 |
|
 |
|
Michael Lampe joined Feinstein Kean Healthcare in 2001 and has managed the New Jersey office since 2004. He has provided communications counsel to clients in the Pharmaceutical and Biotechnology industries for more than a decade. Michael has specific expertise in industry, professional and consumer-focused communications and has a breadth of knowledge of the regulatory and competitive issues surrounding life science communications. Michael manages the development and successful implementation of comprehensive public relations programs for leading pharmaceutical franchises and emerging technologies. He has experience across a range of therapeutic areas including oncology, cardiovascular disease, central nervous system disorders, mental illness, pain management, rheumatology, sleep disorders and women’s health. Michael is expert at developing PR strategies across various stages of product life cycles, from pre-clinical research through patent expiration. He has managed successful product approvals and data presentations at the annual meetings of the American Society of Clinical Oncology, The American Heart Association, among others. Michael also works with clients on anticipating and managing issues, health policy, public health education and corporate positioning programs. Michael gained policy experience while working as a legislative aide for the New Jersey General Assembly and has worked on several political campaigns. Michael graduated from American University with a Master of Arts degree in public communication and from Montclair State University with a Bachelor of Arts degree in political science and a minor in psychology. |
|
||||
 |
||||||
|
|
|
|
|
